ArticlePloS one2025
Cost savings of outpatient versus inpatient hip and knee arthroplasty in Ontario, Canada.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trends and Outcomes in Outpatient Revision Total Hip Arthroplasty: A Retrospective Matched Cohort Study.Hip & pelvis · 2026Article
- Robotic total hip and knee arthroplasty: economic impact and workflow efficiency.Journal of robotic surgery · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHip and knee replacement surgery is one of the most commonly performed elective procedures, accounting for significant healthcare costs and resource utilization. In recent years, the proportion of hip and knee arthroplasties performed in outpatient settings has grown rapidly. Although the safety and effectiveness of outpatient vs. inpatient hip and knee arthroplasty have been documented in the literature, estimates of health system cost-savings in Canada are limited.
methodsWe employed a population-based retrospective cohort study design. We obtained data on patients aged 18-105 years who underwent hip or knee replacement surgery in both inpatient and outpatient settings in Ontario, Canada between 2018/19 and 2022/23. Patients who underwent outpatient hip and knee arthroplasty were matched to inpatient cases using a propensity score based on age, sex, comorbidity, area-level sociodemographic factors, total/partial replacement, and surgery date. We analyzed cost data that included hospitalization and ambulatory care visits, physician billing, home care, and oral medications. We utilized generalized linear models to identify the best fit regression model and estimated the average cost-savings associated with outpatient versus inpatient arthroplasty during the preoperative (30-days before surgery), perioperative (surgery + 30 days), 1-6-month postoperative, 6-12-month postoperative, 12-24-month postoperative, and 24-36-month postoperative periods. The costs were reported in 2023 Canadian dollars.
resultsA total of 35,894 hip arthroplasty patients and 49,597 knee arthroplasty patients were included in our analysis. During the perioperative period, outpatient arthroplasty was less costly than inpatient arthroplasty for hip replacement by $3,859 (95% CI -$4045, -$3745) and for knee replacement by $3,966 ($-4080, $-3851). Over 3 years of follow-up, outpatient arthroplasty was less costly than inpatient arthroplasty for hip replacement by $7058 (-$8086, -$6031) and for knee replacement by $7043 (-$7842, -$6243).
conclusionOutpatient hip and knee arthroplasty is cost-saving both during and beyond the perioperative period in comparison with similar patients who undergo inpatient arthroplasty in Ontario. Policies should be put in place to incentivize continued uptake of outpatient arthroplasty, which we estimate could save the Ontario healthcare system up to $98 million per year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.